y*****l
发帖数: 5997 | 1 公司及药品：
维考公司正在研发的药物很多，和政府合作，开发预治艾滋病毒的疫苗。公司现金充足
，够烧到2012年，近期不用担心稀释圈钱，没有FDA，比较安全。主要炒点是二季度的
melanoma三期。
Allovectin - 7，第三阶段临床试验，治疗转移性黑色素瘤的产品。这个很牛X，非2上
映后，国内谈黑色素色变，到医院祛痣的人，比往年翻了好几倍。
TransVax，一二期临床试验，防止移植后病毒复发和疾病。
还有一些在早期研究中：
H5N1流感疫苗，一期临床试验。
H1N1甲流疫苗，临床前试验
CyMVectin，防止孕前和孕期感染，临床前试验
单纯疱疹2型病毒，研究中，没影儿。
庄家:
这个庄家是玩长期的，看起来很不错，图形走得很规矩，慢牛。
主力平均成本2块，花了7个月的时间吸筹，洗筹，老骥伏枥，志在千里。保守估计庄家
至少要拉到4块才能赚钱。
这个庄很好，贴着10日线走，边拉边歇，没有震仓。不管大盘，埋头拉车一步步往上爬
。走自己的路，让别人跌去吧。
双底图形:
圣诞前，VICL从第一个底部缓缓启动。银杏看到后大喊一声：“放跑了EXEL，下一个可
能会轮到VICL!”大家一听... 阅读全帖 |
|
B*****e
发帖数: 2413 | 2 ER doesn't affect much since vicl has no earning yet. VICL has enough cash
and CEO said vicl will has no new share offering. Actually, I expect VICL
may increase much after ER if VICL licenses its III stage drug to big
company or VICL releases some positive results.
实。 |
|
B*****e
发帖数: 2413 | 3 来自主题: _pennystock版 - VICL I got VICL's cash info from scotttrade.
Cash per share (MRQ) 0.77
Is this correct for VICL's cash availability?
I am a little worried about VICL's cash. If VICL has no enough cash, it
could have new offering soon since they released several small good news
to stimulate stock price. |
|
B*****e
发帖数: 2413 | 4 来自主题: _pennystock版 - VICL I got VICL's cash info from scotttrade.
Cash per share (MRQ) 0.77
Is this correct for VICL's cash availability?
I am a little worried about VICL's cash. If VICL has no enough cash, it
could have new offering soon since they released several small good news
to stimulate stock price. |
|
v**********m
发帖数: 5516 | 5 Vical CEO Discusses Q4 2010 Results - Earnings Call Transcript summaries
1 potential new partnerships
We are projecting a net cash burn for 2011 of $22 million to $27 million,
including projected cash from new or expanded partnerships for which we do
not currently have contracts.
2 VICL will initiate our Phase 3 trial for TransVax CMV vaccine for HCT
patients in the second half of 2011.
3 Allovectin-7 三期数据(银杏曾提到过这个）
VICL expects to lock the clinical data trial database for Allovectin-7 in
the se... 阅读全帖 |
|
v**********m
发帖数: 5516 | 6 Vical CEO Discusses Q4 2010 Results - Earnings Call Transcript summaries
1 potential new partnerships
We are projecting a net cash burn for 2011 of $22 million to $27 million,
including projected cash from new or expanded partnerships for which we do
not currently have contracts.
2 VICL will initiate our Phase 3 trial for TransVax CMV vaccine for HCT
patients in the second half of 2011.
3 Allovectin-7 三期数据(银杏曾提到过这个）
VICL expects to lock the clinical data trial database for Allovectin-7 in
the se... 阅读全帖 |
|
B*****e
发帖数: 2413 | 7 Thanks for VICL. I out half of them and just let other free half freely
running.
I feel uncomfortable with dsco:
1. DSCO's cash is low.
2. Funds only own 15% of dsco unlike vicl's 50%.
3. Figure shape looks ugly.
银杏, work hard! Try to get another VICL! |
|
f**********g
发帖数: 2252 | 8 Sell on news. Did not drop much. may just a correction.
Vical Expects To Begin Phase 3 Trial In 2nd Half >VICL
6 hours 57 minutes ago - DJNF
Vical: European Agency Recommends Efficacy Endpoints For Phase 3
6 hours 58 minutes ago - DJNF
Vical Evaluating Plans For Phase 3 Trial With FDA >VICL
6 hours 59 minutes ago - DJNF |
|
f**********g
发帖数: 2252 | 9 Sell on news. Did not drop much. may just a correction.
Vical Expects To Begin Phase 3 Trial In 2nd Half >VICL
6 hours 57 minutes ago - DJNF
Vical: European Agency Recommends Efficacy Endpoints For Phase 3
6 hours 58 minutes ago - DJNF
Vical Evaluating Plans For Phase 3 Trial With FDA >VICL
6 hours 59 minutes ago - DJNF |
|
B*****e
发帖数: 2413 | 10 My gut feeling and my biological knowledge tell me that VICL will
definitely not be approved by FDA. DATA may be good or bad, depending on
how to analyze the data. However, I am kind of sure that vicl will run to
$3.5 ~4.5 before FDA (nobody knows when). |
|
B*****e
发帖数: 2413 | 11 I upgrade VICL. VICL target: $4~5 in two months; $6~7 before NDA filing.
radar?source=yahoo |
|
y*****l
发帖数: 5997 | 12 多谢生鱼片，专家就是不一样，看来病人用VICL的药能多活好几个月呢。
我们外行只看图，VICL比BMY好多了，BMY批准后也没多大动静，没有油水。 |
|
B*****e
发帖数: 2413 | 13 By the end of this month, vicl will be around 4.00~4.50; By June, vicl
will be over 4.50. |
|
f**********g
发帖数: 2252 | 14 VICL are strong.
Vical to Present at Bank of America/Merrill Lynch Health Care Conference
4 hours 9 minutes ago - PMZ via Comtex
GlobeNewswireVical Incorporated (Nasdaq:VICL) today announced that Vijay B.
Samant, President and Chief Executive Officer, will provide an overview of
the company's technologies, development programs, and outlook on Wednesday,
May 11, at 3:00 p.m. PDT (6:00 p.m. EDT) at the Bank of America/Merrill
Lynch Health Care Conference (Las Vegas, May 10 -- 12).
A webcast of Mr.... 阅读全帖 |
|
|
p****p
发帖数: 3360 | 16 似乎VICL不只这个trial。这次drop了60%多是不是过了？ |
|
S*P
发帖数: 7575 | 17 那三个不是其他公司的吗？
VICL自己的药一个FAIL，两个在临床前呢 |
|
|
|
j*****7
发帖数: 4348 | 20 小生拉潜伏比追涨要放心
VICL明年一季度有个flu swing vaccine的数据（垃圾事件， 不重要）， 二季度Ph
III melanoma的database lock（很重要， 可能有提前炒作）。 公司最近刚增发融了
资， 现在的钱可以撑到2012年。 |
|
y*****l
发帖数: 5997 | 21 ☆─────────────────────────────────────☆
jhsph07 (银杏 - 愚公) 于 (Mon Dec 20 10:33:35 2010, 美东) 提到:
小生拉潜伏比追涨要放心
VICL明年一季度有个flu swing vaccine的数据（垃圾事件， 不重要）， 二季度Ph
III melanoma的database lock（很重要， 可能有提前炒作）。 公司最近刚增发融了
资， 现在的钱可以撑到2012年。
☆─────────────────────────────────────☆
varianinccom (fool) 于 (Mon Dec 20 12:47:17 2010, 美东) 提到:
板凳，记号。
谢谢银杏
☆─────────────────────────────────────☆
MetaIlica (Metallica) 于 (Mon Dec 20 14:30:40 2010, 美东) 提到:
谢银牛，加入watchlist瞅瞅
☆──────────────────────────────... 阅读全帖 |
|
f**********g
发帖数: 2252 | 22 CEO has 526,000 shares!
7.Vical Inc. (VICL): Vical is a $142 million biopharma engaged in the
development of treatments using its DNA delivery technology. They have a
number of drugs at different stages of development and testing. The stock
traded near $4 in September, but poor results from a clinical trial and a
secondary offering priced at $2.25 cut the legs out of the share price. CEO
Vijay Samant picked up 500 shares on February 4 for $1,000. You have to
wonder why it was even worth the trou... 阅读全帖 |
|
y*****l
发帖数: 5997 | 23 ☆─────────────────────────────────────☆
jhsph07 (银杏 - 愚公) 于 (Mon Dec 20 10:33:35 2010, 美东) 提到:
小生拉潜伏比追涨要放心
VICL明年一季度有个flu swing vaccine的数据（垃圾事件， 不重要）， 二季度Ph
III melanoma的database lock（很重要， 可能有提前炒作）。 公司最近刚增发融了
资， 现在的钱可以撑到2012年。
☆─────────────────────────────────────☆
varianinccom (fool) 于 (Mon Dec 20 12:47:17 2010, 美东) 提到:
板凳，记号。
谢谢银杏
☆─────────────────────────────────────☆
MetaIlica (Metallica) 于 (Mon Dec 20 14:30:40 2010, 美东) 提到:
谢银牛，加入watchlist瞅瞅
☆──────────────────────────────... 阅读全帖 |
|
f**********g
发帖数: 2252 | 24 CEO has 526,000 shares!
7.Vical Inc. (VICL): Vical is a $142 million biopharma engaged in the
development of treatments using its DNA delivery technology. They have a
number of drugs at different stages of development and testing. The stock
traded near $4 in September, but poor results from a clinical trial and a
secondary offering priced at $2.25 cut the legs out of the share price. CEO
Vijay Samant picked up 500 shares on February 4 for $1,000. You have to
wonder why it was even worth the trou... 阅读全帖 |
|
f**********g
发帖数: 2252 | 25 来自主题: _pennystock版 - vicl SLOW COW.
Publication Highlights Allovectin-7(R) Phase 2 Safety and Efficacy Results
in Melanoma
6 hours 15 minutes ago - PMZ
GlobeNewswireVical Incorporated (Nasdaq:VICL) today announced a new
publication summarizing results from the company's completed trials of
Allovectin-7(R) including systemic responses and an excellent safety profile
in patients with metastatic melanoma. An article published in the January
issue of Immunotherapy1 noted that the U.S. incidence of melanoma is
increasing rapi... 阅读全帖 |
|
|
f**********g
发帖数: 2252 | 27 来自主题: _pennystock版 - vicl SLOW COW.
Publication Highlights Allovectin-7(R) Phase 2 Safety and Efficacy Results
in Melanoma
6 hours 15 minutes ago - PMZ
GlobeNewswireVical Incorporated (Nasdaq:VICL) today announced a new
publication summarizing results from the company's completed trials of
Allovectin-7(R) including systemic responses and an excellent safety profile
in patients with metastatic melanoma. An article published in the January
issue of Immunotherapy1 noted that the U.S. incidence of melanoma is
increasing rapi... 阅读全帖 |
|
|
M***m
发帖数: 762 | 29 sigh//
I had both of VICL and NBS, and waited them to shoot up one day. |
|
p********e
发帖数: 1960 | 30 same thinking here...will buy VICL with NJJ next week....
and co-waiting |
|
K**********r
发帖数: 2640 | 31 牛jj刚才说：“我什么时候说要买vicl了？”，“我那几个钱 还买这 买那”。
另，牛jj对你收徒表示反感：“跟过老牛一次 赔惨了 账户腰斩”
哈哈哈哈。。。 |
|
g*********1
发帖数: 725 | 32 难友！我也买过NBS在1。4割了，这个vicl捂着，2.08买的，深海中了，估计要去1.5转
转了。太狠了，让我想起俺曾经在中概上的跟头。 |
|
M***m
发帖数: 762 | 33 luckily I had small positions on both stocks and might add some if VICL goes
down to 1.5. I remember that 银杏mentioned he might hold 6 months or longer. |
|
y*****l
发帖数: 5997 | 34 包子我给你发，mark了。
银杏说说VICL吧，我也潜伏不下去了，呵呵。 |
|
f**********g
发帖数: 2252 | 35 It will up today!
报导日期：2011/02/14 08:06
Vical的Allovectin-7第三阶段实验数据获得SMB正面评价
(VICL: 报价, 研究资料) 1.74 : Vical宣布，Allovectin-7第三阶段实验的安全监督
委员会(SMB)完成该实验第五次安全分析，建议继续进行实验，Allovectin-7治疗恶性
黑色素瘤。 |
|
M***m
发帖数: 762 | 36 sigh//
I had both of VICL and NBS, and waited them to shoot up one day. |
|
p********e
发帖数: 1960 | 37 same thinking here...will buy VICL with NJJ next week....
and co-waiting |
|
K**********r
发帖数: 2640 | 38 牛jj刚才说：“我什么时候说要买vicl了？”，“我那几个钱 还买这 买那”。
另，牛jj对你收徒表示反感：“跟过老牛一次 赔惨了 账户腰斩”
哈哈哈哈。。。 |
|
g*********1
发帖数: 725 | 39 难友！我也买过NBS在1。4割了，这个vicl捂着，2.08买的，深海中了，估计要去1.5转
转了。太狠了，让我想起俺曾经在中概上的跟头。 |
|
M***m
发帖数: 762 | 40 luckily I had small positions on both stocks and might add some if VICL goes
down to 1.5. I remember that 银杏mentioned he might hold 6 months or longer. |
|
y*****l
发帖数: 5997 | 41 包子我给你发，mark了。
银杏说说VICL吧，我也潜伏不下去了，呵呵。 |
|
f**********g
发帖数: 2252 | 42 It will up today!
报导日期：2011/02/14 08:06
Vical的Allovectin-7第三阶段实验数据获得SMB正面评价
(VICL: 报价, 研究资料) 1.74 : Vical宣布，Allovectin-7第三阶段实验的安全监督
委员会(SMB)完成该实验第五次安全分析，建议继续进行实验，Allovectin-7治疗恶性
黑色素瘤。 |
|
f**********g
发帖数: 2252 | 43 来自主题: _pennystock版 - VICL Vical Extends Collaboration With U.S. Government for Emerging Disease
Vaccines
3 hours 36 minutes ago - PMZ via Comtex
GlobeNewswireVical Incorporated (Nasdaq:VICL) announced today that the
company has extended its relationship with the U.S. Naval Medical Research
Center (NMRC) to develop its platform technology for the rapid development
and production of vaccines against emerging infectious diseases.
Vical received U.S. government funding from Defense Threat Reduction Agency
and NMRC in 2010 to... 阅读全帖 |
|
B*****e
发帖数: 2413 | 44 来自主题: _pennystock版 - VICL I got 3000 shares @1.91 in last December. Recently VICL released several
small good news and next half of this year it could release some good III
clinical data. I hope it fly and my target is $3.00. |
|
B*****e
发帖数: 2413 | 45 来自主题: _pennystock版 - VICL If always like this, vicl could reach $4~5 in several months. |
|
B*****e
发帖数: 2413 | 46 来自主题: _pennystock版 - VICL I really wish I bought more VICL. |
|
f**********g
发帖数: 2252 | 47 来自主题: _pennystock版 - VICL Vical Extends Collaboration With U.S. Government for Emerging Disease
Vaccines
3 hours 36 minutes ago - PMZ via Comtex
GlobeNewswireVical Incorporated (Nasdaq:VICL) announced today that the
company has extended its relationship with the U.S. Naval Medical Research
Center (NMRC) to develop its platform technology for the rapid development
and production of vaccines against emerging infectious diseases.
Vical received U.S. government funding from Defense Threat Reduction Agency
and NMRC in 2010 to... 阅读全帖 |
|
B*****e
发帖数: 2413 | 48 来自主题: _pennystock版 - VICL I got 3000 shares @1.91 in last December. Recently VICL released several
small good news and next half of this year it could release some good III
clinical data. I hope it fly and my target is $3.00. |
|
B*****e
发帖数: 2413 | 49 来自主题: _pennystock版 - VICL If always like this, vicl could reach $4~5 in several months. |
|
B*****e
发帖数: 2413 | 50 来自主题: _pennystock版 - VICL I really wish I bought more VICL. |
|
